Track insider trades on the go.
Get the app!
iOS
Android
Insider Trades
Latest Trades
Companies
Insiders
Insights
Get the App
Open menu
Back to Trades
Walbert Keli
Director
CIK: 0002051489
Total Volume
$669.5K
Purchases
$0
Sales
$0
Companies
2
Companies Traded
Apellis Pharmaceuticals, Inc. (APLS)
SPRUCE BIOSCIENCES, INC. (SPRB)
Trading History (3 filings)
Apellis Pharmaceuticals, Inc.
(APLS)
Walbert Keli
Director
Filed Jan 5, 2026
Grant
$0
1 grant
View Details
SEC Filing
SPRUCE BIOSCIENCES, INC.
(SPRB)
Walbert Keli
Insider
Filed Dec 15, 2025
Other
$0
View Details
SEC Filing
SPRUCE BIOSCIENCES, INC.
(SPRB)
Walbert Keli
Insider
Filed Dec 15, 2025
Other
$0
View Details
SEC Filing